Peart W S, Roddis S A, Unwin R J
J Physiol. 1986 Apr;373:329-41. doi: 10.1113/jphysiol.1986.sp016050.
Following a random block experimental design in each case, three repeated measurement studies were carried out in three different groups of conscious rabbits, to investigate the renal effects of increasing doses of intravenous calcium chloride (CaCl2) and bovine parathyroid hormone (PTH). In the first study, each rabbit received either CaCl2 (0.15, 0.3, 0.5 or 1.0 mg kg-1 min-1) or vehicle alone (control) for 160 min. In the second study, rabbits were given either PTH (0.15 microgram kg-1 min-1), CaCl2 (1.0 mg kg-1 min-1), PTH plus CaCl2 (0.15 microgram kg-1 min-1 and 1.0 mg kg-1 min-1, respectively) or vehicle alone; PTH was infused for just over 60 min. In the third study, a much smaller dose (0.05 mg kg-1 min-1) of CaCl2 was infused for 100 min. CaCl2 infusion produced a striking fall in fractional excretion of sodium of at least 50% (P less than 0.01), but this was not dose related, being almost maximal at the smaller doses infused. Although this effect was evident in the absence of any changes in total plasma calcium concentration at the lower doses of CaCl2, renal calcium excretion was increased between 2- and 20-fold (P less than 0.01) at all doses infused. Fractional excretion of chloride doubled at the two higher doses of CaCl2 (P less than 0.01), but potassium excretion was unchanged. There were no consistent alterations in mean arterial blood pressure, effective renal plasma flow, glomerular filtration rate or plasma renin activity (PRA); total plasma calcium concentration was consistently elevated only during infusion of the high dose by just under 1 mmol l-1. PTH infusion had no measured effect on fractional excretion of sodium or renal calcium excretion, but doubled fractional potassium excretion (P less than 0.05). Heart rate and PRA increased (P less than 0.01 and less than 0.05, respectively), the latter by 50%, but systemic pressure and renal haemodynamics were not significantly affected. By contrast, PTH infused with CaCl2 produced a 4-fold rise in fractional sodium excretion and although renal calcium excretion remained increased, it was reduced by ca. 80% when compared with renal calcium excretion during infusion of CaCl2 alone. Infusion of PTH alone increased PRA, but when PTH and CaCl2 were infused together, PRA did not change.(ABSTRACT TRUNCATED AT 400 WORDS)
在每种情况下均采用随机区组实验设计,在三组清醒家兔中进行了三项重复测量研究,以探究静脉注射不同剂量氯化钙(CaCl2)和牛甲状旁腺激素(PTH)对肾脏的影响。在第一项研究中,每只家兔接受CaCl2(0.15、0.3、0.5或1.0 mg·kg-1·min-1)或仅接受赋形剂(对照组),持续160分钟。在第二项研究中,给家兔注射PTH(0.15 μg·kg-1·min-1)、CaCl2(1.0 mg·kg-1·min-1)、PTH加CaCl2(分别为0.15 μg·kg-1·min-1和1.0 mg·kg-1·min-1)或仅接受赋形剂;PTH输注时间略超过60分钟。在第三项研究中,输注小得多的剂量(0.05 mg·kg-1·min-1)的CaCl2,持续100分钟。输注CaCl2使钠分数排泄显著下降至少50%(P<0.01),但这与剂量无关,在输注较小剂量时几乎达到最大值。尽管在较低剂量的CaCl2时总血浆钙浓度无任何变化,但所有输注剂量下肾脏钙排泄增加了2至20倍(P<0.01)。在CaCl2的两个较高剂量下,氯分数排泄增加了一倍(P<0.01),但钾排泄未改变。平均动脉血压、有效肾血浆流量、肾小球滤过率或血浆肾素活性(PRA)无一致变化;仅在输注高剂量期间总血浆钙浓度持续升高不到1 mmol·l-1。输注PTH对钠分数排泄或肾脏钙排泄无测量到的影响,但使钾分数排泄增加了一倍(P<0.05)。心率和PRA增加(分别为P<0.01和<0.05),后者增加了50%,但全身血压和肾脏血流动力学未受到显著影响。相比之下,PTH与CaCl2一起输注使钠分数排泄增加了4倍,尽管肾脏钙排泄仍增加,但与单独输注CaCl2时相比减少了约80%。单独输注PTH会增加PRA,但当PTH和CaCl2一起输注时,PRA没有变化。(摘要截断于400字)